{"id":"https://openalex.org/W7203922237","doi":"https://doi.org/10.6084/m9.figshare.31164424","title":"Inhibition of Extracellular Tissue Transglutaminase (TG2) Activity Attenuates Development of Pulmonary Fibrosis in a Novel Rabbit Model (Supplemental Information)","display_name":"Inhibition of Extracellular Tissue Transglutaminase (TG2) Activity Attenuates Development of Pulmonary Fibrosis in a Novel Rabbit Model (Supplemental Information)","publication_year":2026,"publication_date":"2026-08-20","ids":{"openalex":"https://openalex.org/W7203922237","doi":"https://doi.org/10.6084/m9.figshare.31164424"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.31164424","doi":"https://doi.org/10.6084/m9.figshare.31164424","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31164424","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"},"volume":null,"type":"other","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.31164424","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037828808","display_name":"Thomas H. Thatcher","orcid":"https://orcid.org/0000-0001-7177-3041","observed_orcids":["https://orcid.org/0000-0001-7177-3041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Thatcher","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7177-3041","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002911694","display_name":"M.A.T. Freeberg","orcid":"https://orcid.org/0000-0001-7301-7880","observed_orcids":["https://orcid.org/0000-0001-7301-7880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret A. T. Freeberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026791555","display_name":"Sarah Camus","orcid":"https://orcid.org/0000-0003-4250-6133","observed_orcids":["https://orcid.org/0000-0003-4250-6133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah V Camus","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4250-6133","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147765703","display_name":"Linghong Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linghong Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128105778","display_name":"John Atkinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Atkinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044253557","display_name":"Shannon H. Lacy","orcid":"https://orcid.org/0000-0002-8999-4827","observed_orcids":["https://orcid.org/0000-0002-8999-4827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon Lacy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8999-4827","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017903896","display_name":"Wade C. Narrow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wade Narrow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037496357","display_name":"Matthew Kottmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Kottmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095102586","display_name":"Khoa Huynh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khoa Huynh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102842945","display_name":"Jinze Liu","orcid":"https://orcid.org/0000-0003-0555-9412","observed_orcids":["https://orcid.org/0000-0003-0555-9412","https://orcid.org/0000-0003-0692-8793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinze Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0555-9412","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015991699","display_name":"Valentina Robila","orcid":"https://orcid.org/0000-0003-4542-7238","observed_orcids":["https://orcid.org/0000-0003-4542-7238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentina Robila","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4542-7238","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059357637","display_name":"Timothy S. Johnson","orcid":"https://orcid.org/0000-0003-2238-3463","observed_orcids":["https://orcid.org/0000-0003-2238-3463"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy S. Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086563433","display_name":"Patricia J. Sime","orcid":"https://orcid.org/0000-0002-5101-634X","observed_orcids":["https://orcid.org/0000-0002-5101-634X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Sime","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tissue-transglutaminase","display_name":"tissue transglutaminase","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pulmonary-silicosis","display_name":"pulmonary silicosis","score":0.906000018119812},{"id":"https://openalex.org/keywords/rabbit-model","display_name":"rabbit model","score":0.7459999918937683},{"id":"https://openalex.org/keywords/extracellular-matrix-cross-linking","display_name":"extracellular matrix cross-linking","score":0.8410000205039978},{"id":"https://openalex.org/keywords/collagen-deposition","display_name":"collagen deposition","score":0.8370000123977661},{"id":"https://openalex.org/keywords/tgf-beta-activation","display_name":"TGF-beta activation","score":0.8149999976158142}],"concepts":[{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.8251000046730042},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.7886999845504761},{"id":"https://openalex.org/C178498320","wikidata":"https://www.wikidata.org/wiki/Q14903608","display_name":"Tissue transglutaminase","level":3,"score":0.7703999876976013},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.7666000127792358},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.7279999852180481},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.6938999891281128},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.5422999858856201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5306000113487244},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4957999885082245},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4927000105381012},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4341999888420105},{"id":"https://openalex.org/C2780381497","wikidata":"https://www.wikidata.org/wiki/Q463418","display_name":"Fibroblast","level":3,"score":0.43309998512268066},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.42739999294281006},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3991999924182892},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.3871000111103058},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35100001096725464},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.3499999940395355},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.3183000087738037},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3151000142097473},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C207865475","wikidata":"https://www.wikidata.org/wiki/Q1467330","display_name":"Myofibroblast","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26330000162124634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25200000405311584}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.31164424","doi":"https://doi.org/10.6084/m9.figshare.31164424","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31164424","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"},{"id":"doi:10.6084/m9.figshare.31164424.v1","doi":"https://doi.org/10.6084/m9.figshare.31164424.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31164424.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.31164424","doi":"https://doi.org/10.6084/m9.figshare.31164424","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31164424","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1466761634","display_name":"Pathways to Fibrosis","funder_award_id":"R03HL095402","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6371730295","display_name":"R01 Transfer from U. of Rochester- Lactate Promotes Scarring After Irradiation","funder_award_id":"R01HL127001","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G846783468","display_name":"Tissue stiffness promotes pro-fibrotic metabolic dysregulation in lung fibrosis","funder_award_id":"F32HL154525","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7214208315","https://openalex.org/W7161549329","https://openalex.org/W2107260822","https://openalex.org/W2945169905","https://openalex.org/W3003775531","https://openalex.org/W3124716271","https://openalex.org/W2167430593","https://openalex.org/W7161575322","https://openalex.org/W7048028984","https://openalex.org/W4230031234"],"abstract_inverted_index":{"Pulmonary":[0],"fibrosis":[1,26,45,55,101,130,160,179,210],"is":[2,21],"an":[3],"interstitial":[4,148],"scarring":[5],"disease":[6],"of":[7,41,63,83,119,177,196,209,221],"the":[8,39,120,162,168,175,207],"lung":[9,25,48,100],"characterized":[10],"by":[11,27,91,131],"poor":[12],"prognosis":[13],"and":[14,32,57,86,95,105,128,186],"limited":[15],"treatment":[16,140,218],"options.":[17],"Tissue":[18],"transglutaminase":[19],"(TG2)":[20],"believed":[22],"to":[23,43,72,156,158,167,174],"promote":[24],"crosslinking":[28,199],"extracellular":[29,74,198,222],"matrix":[30,75],"components":[31],"activating":[33],"latent":[34],"TGFb.":[35],"This":[36],"study":[37],"evaluates":[38],"contribution":[40],"TG2":[42,69,84,107,112,126,151,171,197,223],"pulmonary":[44,54,64,159,178],"in":[46,58,92,135,147,161,182,213],"human":[47,121,183],"tissue":[49,79,184],"from":[50],"donors":[51],"with":[52,102,111,145,191,201],"idiopathic":[53],"(IPF)":[56],"a":[59,67,116,137,202,214],"novel":[60],"rabbit":[61],"model":[62],"silicosis,":[65],"using":[66],"therapeutic":[68,122,203,227],"blocking":[70],"antibody":[71,114,123,204],"inhibit":[73],"crosslinking.":[76],"Human":[77],"IPF":[78],"expressed":[80],"elevated":[81],"levels":[82],"antigen":[85],"Tgm2":[87],"RNA":[88],"as":[89,180],"detected":[90],"situ":[93],"hybridization.":[94],"antigen.":[96],"Silica-treated":[97],"rabbits":[98],"developed":[99],"increased":[103,106],"collagen":[104,149],"enzymatic":[108],"activity.":[109],"Treatment":[110],"inhibitory":[113],"rbBB7,":[115],"rabbitized":[117],"version":[118],"zampilimab,":[124],"reduced":[125],"activity":[127,200,224],"attenuated":[129,206],"50%":[132],"when":[133,211],"used":[134],"either":[136],"prevention":[138,215],"or":[139,217],"strategy,":[141],"which":[142],"was":[143],"associated,":[144],"reductions":[146],"accumulation.":[150],"has":[152,225],"previously":[153],"been":[154],"reported":[155],"contribute":[157],"mouse":[163],"bleomycin":[164],"model,":[165],"leading":[166],"conclusion":[169],"that":[170],"contributes":[172],"significantly":[173,205],"pathogenesis":[176],"demonstrated":[181],"specimens":[185],"two":[187],"independent":[188],"animal":[189],"models":[190],"different":[192],"fibrotic":[193],"stimuli.":[194],"Blockade":[195,220],"development":[208],"given":[212],"strategy":[216],"strategy.":[219],"exciting":[226],"potential.":[228]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-08-22T00:00:00"}